Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Chul Kim is an Associate Professor at Georgetown University focusing on thoracic oncology. His goal as a thoracic medical oncologist is to introduce innovative cancer therapies into clinical practice, and he is devoted to formulating clinical trials aimed at promoting personalized cancer treatments.

Program: East Asian LCVL 2023 - Korean Language
English: Oncologists speak on topics in lung cancer, including risk factors, targeted therapy options, and the importance of genetic testing.

Korean: 종양학자들은 위험 요인, 표적 치료 옵션, 유전자 검사의 중요성 등 폐암 관련 주제에 대해 강연합니다.

Author
Chul Kim, MD - Guest Faculty
Image
East Asian Lung Cancer

In this video series, Dr. Chul Kim translates discussions on lung cancer in Korean.  Videos include information on SCLC and NSCLC including statistics and risk factors.

To watch the full playlist click here.

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora